Skip to main content
MDCXW logo

MDCXW · Medicus Pharma Ltd.

Track MDCXW — free
$0.24 At close · Oct 27
Market Cap
$3.17M
Shares
1.26M
Volume · Oct 27 674 Avg daily vol (3M) 1291

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.24 Open$0.34 Day$0.24–0.34 Available close range$0.20–0.51 Avg vol available · 28d1K DataJul 2026–Oct 2026 Filing10-Q · Aug 12

The closing range uses available history since Jul 23, 2026; less than a full year is stored.

Latest filings

8-K Delisting notice or listing transfer · filed Oct 23, 2026

Medicus Pharma Ltd. regained Nasdaq compliance with the $1.00 minimum bid price requirement on October 23, 2026, closing the matter after Nasdaq had determined on October 20, 2026 to delist its shares and warrants.

Read the 8-K
10-Q filed Aug 12, 2026
Read the 10-Q
All filings

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
3 of 27 funds reported for Sep 30 · net -310 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
27 holders — near 1-yr high, broad support
Price context
position in its available closing range
Range low $0 Now $0 · 13% Range high $1

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MDCXW
Medicus Pharma Ltd.
this stock
$3.17M — — — —
LLY
ELI LILLY & Co
$1.21T +19.3% +44.7% 43.0 0.7%
JNJ
Johnson & Johnson
$646.92B +29.9% +6.0% 40.8 0.7%
ABBV
AbbVie Inc.
$505.91B +25.3% +8.6% 80.9 0.9%
MRK
Merck & Co., Inc.
$346.91B +34.7% +1.3% 112.5 1.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
26
% held
12.9%
Reported
3 of 27
Top holder
Interchange Capital Partn…
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
555
Value
$83
As of
Sep 29, 2026
View
Financials
Financials
Net income (FY)
$-47.3M
EPS diluted
$-137.00
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 23, 2026
This year
20

Medicus Pharma Ltd. regained Nasdaq compliance with the $1.00 minimum bid price requirement on October 23, 2026, closing the matter after Nasdaq had determined on October 20, 2026 to delist its shares and warrants.

View
Proposed Sales
Value
$23.1M
Shares
118.0K
Filed
May 20, 2025
View
Exempt Offerings
Offering
$11.0M
Filed
Jul 8, 2024
View
Earnings & Events
Webcasts
Last webcast
Mar 26, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
MDCXW +20.0% -45.5% — -20.0% —
SPY +0.1% +0.7% +4.9% +0.9% +12.9%
vs SPY +19.9% -46.2% — -20.9% —
Key facts CIK 1997296 CUSIP 58471K202 Visit website Investor relations